{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T08:14:09Z","timestamp":1793261649450,"version":"4.5.0"},"reference-count":18,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,10]]},"DOI":"10.1097\/01.ajp.0000210917.18536.0d","type":"journal-article","created":{"date-parts":[[2006,9,13]],"date-time":"2006-09-13T08:09:04Z","timestamp":1158134944000},"page":"677-680","source":"Crossref","is-referenced-by-count":41,"title":["Sumatriptan Alleviates Pain in Patients With Trigeminal Neuralgia"],"prefix":"10.1097","volume":"22","author":[{"given":"Akifumi","family":"Kanai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asaha","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoru","family":"Osawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumio","family":"Hoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-2-20210204","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1046\/j.1526-4610.2001.01154-5.x","article-title":"Antiepileptic drugs in the management of cluster headache and trigeminal neuralgia","volume":"41","author":"Rozen","year":"2000","journal-title":"Headache"},{"key":"R2-2-20210204","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1056\/NEJM199604253341701","article-title":"The long-term outcome of microvascular decompression for trigeminal neuralgia","volume":"334","author":"Barker","year":"1996","journal-title":"N Engl J Med"},{"key":"R3-2-20210204","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/S0140-6736(62)91847-0","article-title":"Trigeminal neuralgia: its treatment with a new anticonvulsant drug (G-32883)","volume":"i","author":"Blom","year":"1962","journal-title":"Lancet"},{"key":"R4-2-20210204","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1016\/S0140-6736(01)06711-3","article-title":"Oral triptans (serotonin 5-HT1B\/1D agonists) in acute migraine treatment: a meta-analysis of 53 trials","volume":"358","author":"Ferrari","year":"2001","journal-title":"Lancet"},{"key":"R5-2-20210204","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1159\/000116756","article-title":"The clinical pharmacology, pharmacokinetics and metabolism of sumatriptan","volume":"31","author":"Fowler","year":"1991","journal-title":"Eur Neurol"},{"key":"R6-2-20210204","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1046\/j.1526-4610.1998.3803184.x","article-title":"Efficacy and safety of sumatriptan tablets (25\u2009mg, 50\u2009mg, 100\u2009mg) in the acute treatment of migraine: defining the optimum doses of oral supatriptan","volume":"38","author":"Pfaffenrath","year":"1998","journal-title":"Headache"},{"issue":"(Suppl)","key":"R7-2-20210204","first-page":"7","article-title":"A double-blind placebo-controlled study assessing the efficacy and tolerability of 50\u2009mg sumatriptan tablets in the acute treatment of migraine. Sumatriptan Tablets S2CM07 Study Group","volume":"105","author":"Savani","year":"1999","journal-title":"Int J Clin Pract"},{"key":"R8-2-20210204","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/S0028-3908(02)00119-3","article-title":"Large amplitude 5-HT1A receptor activation: a new mechanism of profound central analgesia","volume":"43","author":"Colpaert","year":"2002","journal-title":"Neuropharmacology"},{"key":"R9-2-20210204","first-page":"219","article-title":"Differential expression of sumatriptan-sensitive 5-hydroxy-tryptamine receptors in human trigeminal ganglia and cerebral blood vessels","volume":"50","author":"Bouchelet","year":"1996","journal-title":"Mol Pharmacol"},{"key":"R10-2-20210204","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0304-3959(00)00475-9","article-title":"An in vivo rat model to study calcitonin gene related peptide release following activation of the trigeminal vascular system","volume":"92","author":"Limmroth","year":"2001","journal-title":"Pain"},{"key":"R11-2-20210204","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/00002508-198906000-00011","article-title":"Percutaneous injection of glycerol for the treatment of trigeminal neuralgia","volume":"5","author":"Waltz","year":"1989","journal-title":"Clin J Pain"},{"key":"R12-2-20210204","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/BF01541793","article-title":"Glycerol injection to the rat trigeminal nerve: histological and immunohistochemical studies","volume":"119","author":"Hara","year":"1992","journal-title":"Acta Neurochir (Wien)"},{"key":"R13-2-20210204","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.1523\/JNEUROSCI.08-07-02468.1988","article-title":"Enrichment of a vasoactive neuropeptide (calcitonin gene-related peptide) in the trigeminal sensory projection to the intracranial arteries","volume":"8","author":"O'Connor","year":"1988","journal-title":"J Neurosci"},{"key":"R14-2-20210204","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/0014-2999(85)90706-X","article-title":"Calcitonin gene-related peptide is a potent inhibitor of substance P degradation","volume":"115","author":"Le Greves","year":"1985","journal-title":"Eur J Pharmacol"},{"key":"R15-2-20210204","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/0006-8993(87)90074-6","article-title":"Calcitonin gene-related peptide promotes mechanical nociception by potentiating release of substance P from the spinal dorsal horn in rats","volume":"403","author":"Oku","year":"1987","journal-title":"Brain Res"},{"key":"R16-2-20210204","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/ana.410230214","article-title":"Release of vasoactive peptides in the extracerebral circulation of humans and the cat during activation of the trigeminovascular system","volume":"23","author":"Goadsby","year":"1988","journal-title":"Ann Neurol"},{"key":"R17-2-20210204","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1046\/j.1526-4610.1997.3704211.x","article-title":"Cerebrospinal fluid neuropeptides and monoaminergic transmitters in patients with trigeminal neuralgia","volume":"37","author":"Strittmatter","year":"1997","journal-title":"Headache"},{"key":"R18-2-20210204","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1093\/brain\/124.12.2347","article-title":"Trigeminal neuralgia: pathology and pathogenesis","volume":"124","author":"Love","year":"2001","journal-title":"Brain"}],"container-title":["The Clinical Journal of Pain"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00002508-200610000-00002","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,13]],"date-time":"2021-04-13T02:25:30Z","timestamp":1618280730000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00002508-200610000-00002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,10]]},"references-count":18,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2006]]}},"URL":"https:\/\/doi.org\/10.1097\/01.ajp.0000210917.18536.0d","relation":{},"ISSN":["0749-8047"],"issn-type":[{"value":"0749-8047","type":"print"}],"subject":[],"published":{"date-parts":[[2006,10]]}}}